{"schema_version":"secwatch.filing_event.v1","accession":"0001803737-23-000145","form_type":"8-K","ticker":"EHAB","cik":"0001803737","company_name":"Enhabit, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.312314+00:00","generated_at":"2026-06-11T23:03:18.951087+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Enhabit Q2 net loss $74.1M; cuts FY23 guidance; plans strategic alternatives process","bullets":["Q2 net loss $74.1M ($1.49 diluted loss per share); adjusted EPS $0.04, down 91.5% YoY.","Revenue $262.3M, down 2.1% YoY; adjusted EBITDA $23.9M, down 40.7% YoY.","Full-year 2023 guidance slashed: revenue $1,057-$1,065M (from $1,110-$1,140M), adjusted EBITDA $100-$107M.","Announced intent to launch strategic alternatives process, including potential sale, subject to Tax Matters Agreement conditions with Encompass Health."],"urls":{"canonical":"https://secwatch.observer/filing/0001803737-23-000145","json":"https://secwatch.observer/filing/0001803737-23-000145.json","markdown":"https://secwatch.observer/filing/0001803737-23-000145.md","text":"https://secwatch.observer/filing/0001803737-23-000145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803737/000180373723000145/0001803737-23-000145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803737/000180373723000145/ehab-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T23:03:18.951087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}